NJ Shareholder Suit Over Nymox's Prostate Drug Trials Tossed
A New Jersey federal judge on Wednesday released Nymox Pharmaceutical Corp. and its founder from a class action securities suit, concluding that shareholders failed to demonstrate a purposeful scheme to misrepresent...To view the full article, register now.
Already a subscriber? Click here to view full article